Answers are grounded in this paper and cite their sources.
Introduction Bronchopulmonary dysplasia (BPD) is a common and devastating chronic lung disease in preterm infants. The role of the gut microbiome and metabolome in its pathogenesis remains largely unknown. This study aimed to characterize the longitudinal dynamics of gut microbiota and fecal metabolome in preterm infants who developed BPD. Methods Fecal samples were collected at three time points (24 h, 14 d, and 28 d after birth) from a prospective cohort of preterm infants. 16S rRNA sequencing and liquid chromatography–mass spectrometry/gas chromatography–mass spectrometry (LC–MS/GC–MS) metabolomics were performed. Integrated multi-omics analyses, including permutational multivariate analysis of variance (PERMANOVA), partial least squares discriminant analysis (PLS-DA), correlation networks, Procrustes analysis, and PICRUSt2-based functional prediction, were used to identify exploratory microbial and metabolic signatures. Results Infants who developed BPD exhibited distinct gut microbiota compositions and fecal metabolite profiles as early as 24 h after birth, before clinical diagnosis. These differences were most pronounced at early time points and were no longer statistically significant by day 28. Exploratory LEfSe analysis identified six leading genus-level taxa at 24 h. Microbe–metabolite correlation networks revealed extensive associations at the pooled level, and Procrustes analysis demonstrated significant structural concordance at 14 d. Pathway enrichment and PICRUSt2 prediction identified retinol metabolism and other pathways with distinct temporal dynamics. Importantly, rigorous sensitivity analyses revealed that these BPD-associated differences were highly confounded by gestational age and were largely attenuated after adjustment. Discussion Early-life gut microbial and metabolic alterations are associated with the subsequent development of BPD, though they cannot be statistically separated from the effects of prematurity. These findings provide a multi-omics resource for generating hypotheses regarding the gut–lung axis and highlight the need for future gestational-age-matched studies to determine whether early vitamin A metabolism or other pathways could serve as biomarkers or therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: